FR2407720A1
Expired / Lapsed
FR
⏱️ 0.0 years remaining
Oral sustained-action capsule formulations - of drug and excipient which swells in contact with digestive juices
Assignee: Merck Sante SAS
•
Filing: 1977-11-08
•
Granted: —
•
Expires: 1997-11-08
Abstract
Abstract Oral compsns. with sustained activity comprising the active drug and an excipient which swells in contact with digestive juices, this being =45% w/w of the compsn., contained in hard gelatin capsules. The compsns. may contain drugs such as aspirin, nitrofurantoin and naftidrofuryl. Swelling agents include guar gum, tragacanth and hydroxypropylmethylcellulose. A preferred agent with aspirin is 40-45% w/w of hydroxy-propylmethylcellulose; for naftidrofuryl 20-25% w/w of swelling agent. Conventional additives such as lubricants and fillers may be used, e.g. magnesium stearate, lactose kaolin, colloidal silica.
Inventors
- 👤 Jean-Claude Lechevin
- 👤 Jean-Noel Treilles
- 👤 Francoise Merle
- 👤 Maryse Belleville
Bibliographic Details
Application Number
—
Jurisdiction
FR
Data Source
google_patents
Last Synchronized
2026-11-08 18:12
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/48; A61K9/4841; A61K9/4866
Claims Analysis
Total Claims: 0
No claims parsed yet. Click Sync Now above to re-index claims from Google Patents.
References Cited (Backward Citations)
DE1445105A1
Cited
US3247066A
Cited
FR1468716A
Cited
US3427378A
Cited
US3574820A
Cited
LU61171A1
Cited
FR2118492A5
Cited
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.